2Takashi T,Hagowara A,Shimotsuma M,et al.Prophylaxis and treatment of peritoneal carcinomatosis:intraperitoneal chemotherapy with mitomycin C bound to activated carbon particles[J].World J Sur,1995,19:265.
3Kailara N,Zitsuka Y,Kimura A,et al.Relationship between area of serosal invasion and prognosis with gastric carcinoma[J].Cabeer,1987,60(2):136.
4Elias D,E Otmany A,Bonnay M,et al.Human pharmacokinetic study of heated intraperitoneal oxaliplatin in increasingly hypotonic solutions after complete resection of peritoneal carcinomatosils[J].Oncology,2002,63:346-352.
5Witkamp A J,de Beer E,Van Goethem R,et al.Rationale and techniques of intra-operative hyperthermic intrapcritoneal chemotherapy[J].Cancer Treat Rev,2001,27:365-374.
6Sugarbalker P H.Cwnliffe W J,Belliveau J,et al.Rationale for interrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer[J].Semin Oncol,1989,16(1):83.
7Stephen R L,Novak J M,Jensen EM,et al.Effect of osmotic pressure on uptake of chenotherapeutic agents by carcinoma cells[J].Cancer Res,1990,50:4704-4708.
